Quantitative Pupillometry in Brain Injury Children : Variation After Osmotherapy (OSMOPUPILLO)

March 27, 2025 updated by: University Hospital, Grenoble

Intracranial hypertension (ICH) is a common and serious complication in children admitted to pediatric intensive care units. It is primarily caused by traumatic brain injury but can also result from brain malformations, brain tumors, or neuro-meningeal infections. Rapid identification of ICH in acute settings is crucial to ensure prompt management and mitigate potential consequences, such as severe neurological sequelae or death.

The assessment of the pupillary light reflex is one of the key clinical parameters used to identify ICH in children with neurological injuries. This clinical sign is correlated with neurological prognosis. During an episode of ICH, regardless of the underlying cause, the oculomotor nerve becomes compressed between the midbrain and the temporal lobe, leading to anisocoria (unequal pupil sizes) and loss of pupillary reactivity. Other factors, such as episodes of ischemia or hypoperfusion in the midbrain, can also contribute to decreased pupillary reactivity.

Study Overview

Status

Recruiting

Detailed Description

Traditionally, the pupillary light reflex is assessed using a simple light source, with subjective evaluation by a healthcare professional. However, this method has significant inter- and intra-individual variability. Quantitative pupillometry offers a more objective and reproducible way to evaluate pupillary reactivity. In adults, some parameters are well-known indicators of ICH, such as a constriction velocity of less than 0.6 mm/sec and a constriction percentage below 10%. The constriction percentage can be simplified with the Neurological Pupil index (NPI), which ranges from 0 to 5. An NPI of 4 or 5 is considered to indicate good pupillary reactivity. The two quantitative pupillometers currently on the market (Neurolight, Neuroptics) appear to provide similar data for most variables assessed. However, there are few studies evaluating this tool in pediatric patients with neurological injuries.

One study on quantitative pupillometry found that children with neurological injuries and an intracranial pressure (ICP) above 20 mmHg had significantly lower pupillary reactivity, NPI, constriction percentage, and dilation and constriction velocities compared to children without ICH.

Osmotherapy is a commonly used pharmacological intervention in pediatrics to lower intracranial pressure and improve cerebral perfusion pressure. Based on the work of Freeman et al., we hypothesize that the pupillary constriction percentage improves after osmotherapy in children with neurological injuries.

Study Type

Observational

Enrollment (Estimated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • La tronche, France, 38700
        • Not yet recruiting
        • Grenoble Alpes University Hospital
        • Contact:
    • Isere
      • Grenoble, Isere, France, 387000
        • Recruiting
        • Chu Grenoble Alpes
        • Contact:
        • Contact:
        • Contact:
          • SARAH ss SINTZEL STRIPPOLI, Doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

children aged 1 month to 17 years with brain lesion receiving osmotherapy

Description

Inclusion Criteria:

  • Hospitalized in a pediatric intensive care unit or neurosurgical intensive care unit
  • Inclusion within 24 hours of ICU admission
  • with clinically suspected HTIC (disorders of consciousness with transcranial Doppler abnormality, symptoms of involvement, poor cerebral perfusion pressure) for which osmotherapy is prescribed

Exclusion Criteria:

  • Presence of eye damage (or antecedent)
  • Refusal by parents and/or child Opposition by child or parental guardians.
  • Persons not affiliated to the social security system.
  • Protected persons (under guardianship, curatorship, pregnant or breast- feeding women, persons deprived of their liberty, persons not subject to a psychiatric measure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
severe head trauma in children with osmotherapy treatment
Admission to the pediatric intensive care or neurosurgical intensive care unit, pupillometry measurement before and after osmotherapy treatment
Pupillometry measurements at 5 and 25 minutes for children treated with osmotherapy, followed by measurements twice a day during hospitalization in the intensive care unit
describe the feasibility of pupillometry measurements in sedated but non-cerebrosed children in intensive care and the operating room
pupillometry measurement in non-cerebral pediatric patients
feasibility of pupillometry in children for different age groups and obtain baseline values for non-neurologically sedated children in 4 age groups from 0 to 17 years of age in intensive care and the operating room
Pupillometry measurements at 5 and 25 minutes for children treated with osmotherapy, followed by measurements twice a day during hospitalization in the intensive care unit
describe the feasibility of pupillometry measurements in sedated but non-cerebrosed children in intensive care and the operating room

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
to describe and evaluate the variation in the percentage of pupillary constriction (CON) before, and after osmotherapy in neuro-injured children.
Time Frame: at 10 days

Delta (in percentage difference, and in delta of values) of the constriction (CON) between the last available measurement before the osmotherapy was started, and the measurement 5 minutes after the end (at 25 minutes after the start of the osmotherapy).

For each child, the eye with the lowest constriction (CON) value before osmotherapy will be considered.

at 10 days
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
Success rate in obtaining pupillometric values for different age groups. Pupillometric values: QPI (quantitative pupillometry index) in intensive care and the operating room
at 1 minute and 25 minutes
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
Success rate in obtaining pupillometric values for different age groups. Pupillometric values: latency (LAT) in intensive care and the operating room
at 1 minute and 25 minutes
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
Success rate in obtaining pupillometric values for different age groups. Pupillometric values: constriction velocity (ACV) and dilatation velocity (ADV) in mm/sec in intensive care and the operating room
at 1 minute and 25 minutes
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
Success rate in obtaining pupillometric values for different age groups. Pupillometric values: minimum (MIN) and maximum (MAX) pupillary diameter in mm in intensive care and the operating room
at 1 minute and 25 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (LAT).
Time Frame: per 12h during 10 days
Assessing the association between latency in sec (LAT) and ICP (mmhg)
per 12h during 10 days
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (QPI).
Time Frame: per 12h during 10 days
Assessing the association between measurements of pupillometry, QPI, quantitative pupillometry index
per 12h during 10 days
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values.(CON)
Time Frame: per 12h during 10 days
Assessing the association between measurements of pupillometry, percentage of constriction (CON) and ICP.
per 12h during 10 days
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (Max; Min)
Time Frame: per 12h during 10 days
To asses association between intracranial pressure and minimum et maximum pupillary diameter (in mm).
per 12h during 10 days
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values. (ACV and ADV)
Time Frame: per 12h during 10 days
To asses association between ICP and pupillometry values : constriction velocity (ACV) and dilatation velocity (ADV) in mm.sec
per 12h during 10 days
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age
Time Frame: at 1 and 25 minutes
measurement of pupillometric parameters : latence (in sec)
at 1 and 25 minutes
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 minutes
measurement of pupillometric parameters : quantitative pupillometry index, pupil constriction
at 1 and 25 minutes
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 minutes
measurement of pupillometric parameters : Minimum and maximum pupillary diameter (in mm)
at 1 and 25 minutes
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 min
measurement of pupillometric parameters constriction velocity (ACV), dilatation velocity (ADV) in mm/sec
at 1 and 25 min
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes
Measure of pupillometry: CON and QPI after osmotherapy administration
at 15 , 25, 35, 45, 60, 120, 240 minutes
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: [Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
Measure of pupillometry : constriction velocity (ACV), dilatation velocity (ADV) in mm/sec
[Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: [Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
Measure of pupillometry: latence (in mm)
[Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes
Measure of pupillometry: Min and max pupillary diameter in mm.
at 15 , 25, 35, 45, 60, 120, 240 minutes
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
Repeated pupillometry measurements : (LAT) latence in sec and transcranial doppler
2 times a day for 10 days or on discharge from hospital
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
Repeated pupillometry measurements QPI and CON and transcranial doppler
2 times a day for 10 days or on discharge from hospital
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
Repeated pupillometry measurements (Maximum and minimum pupillary diameter in mm) and transcranial doppler
2 times a day for 10 days or on discharge from hospital
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
Repeated pupillometry measurements (constriction velocity (ACV) and dilatation velocity (ADV) in mm.sec) and transcranial doppler
2 times a day for 10 days or on discharge from hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2024

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

April 1, 2028

Study Registration Dates

First Submitted

September 23, 2024

First Submitted That Met QC Criteria

October 14, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

April 2, 2025

Last Update Submitted That Met QC Criteria

March 27, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is an observational study, which does not modify the management of children with brain lesions, nor does it generate additional therapies.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children Brain Injury

Clinical Trials on pupillometer

Subscribe